Vancomycin Patent Expiration
Vancomycin is Used for treating bacterial infections. It was first introduced by Xellia Pharmaceuticals Aps
Vancomycin Patents
Given below is the list of patents protecting Vancomycin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vancomycin | US10039804 | Glycopeptide compositions | Nov 06, 2035 | Xellia Pharms Aps |
| Vancomycin | US10188697 | Glycopeptide compositions | Nov 06, 2035 | Xellia Pharms Aps |
| Vancomycin | US10849956 | Glycopeptide compositions | Nov 06, 2035 | Xellia Pharms Aps |
| Vancomycin | US11000567 | Glycopeptide compositions | Nov 06, 2035 | Xellia Pharms Aps |
| Vancomycin | US11517609 | Glycopeptide compositions | Nov 06, 2035 | Xellia Pharms Aps |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Vancomycin's patents.
Latest Legal Activities on Vancomycin's Patents
Given below is the list recent legal activities going on the following patents of Vancomycin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 15 May, 2024 | US10849956 |
| Email Notification Critical | 28 Dec, 2022 | US11000567 |
| Email Notification Critical | 28 Dec, 2022 | US10849956 |
| Change in Power of Attorney (May Include Associate POA) Critical | 28 Dec, 2022 | US10188697 |
| Change in Power of Attorney (May Include Associate POA) Critical | 28 Dec, 2022 | US11000567 |
| Email Notification Critical | 28 Dec, 2022 | US10039804 |
| Change in Power of Attorney (May Include Associate POA) Critical | 28 Dec, 2022 | US10849956 |
| Email Notification Critical | 28 Dec, 2022 | US10188697 |
| Change in Power of Attorney (May Include Associate POA) Critical | 28 Dec, 2022 | US10039804 |
| Change in Power of Attorney (May Include Associate POA) Critical | 28 Dec, 2022 | US11517609 |
Vancomycin's Family Patents
